Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
21.7%
% of THNR's 23 holdings also in MEDX
16.7%
% of MEDX's 30 holdings also in THNR
Overlap by Weight
Sector Drift (THNR minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.7% | 16.8% | 15.7% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.7% | 5.6% | 4.7% |
|
AMGEN INC | 4.6% | 6.3% | 4.6% |
|
PFIZER INC | 4.6% | 4.0% | 4.0% |
|
MERCK & CO. INC. | 4.7% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
THNR Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 13.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.2% |
|
WEST PHARMACEUTICAL SERVICES | 5.1% |
|
THERMO FISHER SCIENTIFIC INC | 5.0% |
 |
ROCHE HOLDING LTD | 4.7% |
 |
INNOVENT BIOLOGICS, INC. | 4.7% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.5% |
|
HIMS & HERS HEALTH, INC. CLASS A | 3.6% |
|
MITSUBISHI CHEMICAL HOLDINGS | 3.5% |
|
ZEALAND PHARMA A/S | 2.7% |
THNR Underweight Relative to MEDX
|
ABBVIE INC | -9.6% |
|
NOVARTIS AG-ADR | -6.6% |
|
BRISTOL-MYERS SQUIBB CO | -6.5% |
|
JOHNSON & JOHNSON | -5.1% |
|
ALNYLAM PHARMACEUTICALS INC | -4.7% |
 |
ALKERMES PLC | -4.7% |
|
REGENERON PHARMACEUTICALS | -2.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
BIOGEN IDEC INC | -2.6% |
|
CRISPR THERAPEUTICS AG | -2.4% |